Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Processes × pembrolizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 107 Parkinson Disease 4, Autosomal Dominant Lewy Body 99 Melanoma 68 Squamous Cell Carcinoma of Head and Neck 41 Neoplasms 36 Colorectal Neoplasms 31 Breast Neoplasms 31 Triple Negative Breast Neoplasms 26 Stomach Neoplasms 26 Neoplasm Metastasis 26 Urinary Bladder Neoplasms 25 Head and Neck Neoplasms 25 Ovarian Neoplasms 24 Lung Neoplasms 23 Carcinoma, Renal Cell 23 Carcinoma, Transitional Cell 20 Carcinoma, Hepatocellular 18 Pancreatic Neoplasms 16 Esophageal Neoplasms 16 Fallopian Tube Neoplasms 14 Endometrial Neoplasms 13 Recurrence 12 Prostatic Neoplasms 12 Multiple Myeloma 12 Carcinoma 12 Carcinoma, Squamous Cell 11 Sarcoma 10 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Follicular 9 Leukemia, Myeloid, Acute 9

Interventions

bosutinib 1 Imatinib Mesylate 1 Cholecalciferol 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡